These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 30097118)
1. Hypericin inhibits hepatitis C virus replication via deacetylation and down-regulation of heme oxygenase-1. Shih CM; Wu CH; Wu WJ; Hsiao YM; Ko JL Phytomedicine; 2018 Jul; 46():193-198. PubMed ID: 30097118 [TBL] [Abstract][Full Text] [Related]
2. Celastrol inhibits hepatitis C virus replication by upregulating heme oxygenase-1 via the JNK MAPK/Nrf2 pathway in human hepatoma cells. Tseng CK; Hsu SP; Lin CK; Wu YH; Lee JC; Young KC Antiviral Res; 2017 Oct; 146():191-200. PubMed ID: 28935193 [TBL] [Abstract][Full Text] [Related]
3. Curcumin inhibits HCV replication by induction of heme oxygenase-1 and suppression of AKT. Chen MH; Lee MY; Chuang JJ; Li YZ; Ning ST; Chen JC; Liu YW Int J Mol Med; 2012 Nov; 30(5):1021-8. PubMed ID: 22922731 [TBL] [Abstract][Full Text] [Related]
4. Andrographolide exerts anti-hepatitis C virus activity by up-regulating haeme oxygenase-1 via the p38 MAPK/Nrf2 pathway in human hepatoma cells. Lee JC; Tseng CK; Young KC; Sun HY; Wang SW; Chen WC; Lin CK; Wu YH Br J Pharmacol; 2014 Jan; 171(1):237-52. PubMed ID: 24117426 [TBL] [Abstract][Full Text] [Related]
5. Lucidone suppresses hepatitis C virus replication by Nrf2-mediated heme oxygenase-1 induction. Chen WC; Wang SY; Chiu CC; Tseng CK; Lin CK; Wang HC; Lee JC Antimicrob Agents Chemother; 2013 Mar; 57(3):1180-91. PubMed ID: 23254429 [TBL] [Abstract][Full Text] [Related]
6. Reciprocal effects of micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus genes in human hepatocytes. Shan Y; Zheng J; Lambrecht RW; Bonkovsky HL Gastroenterology; 2007 Oct; 133(4):1166-74. PubMed ID: 17919492 [TBL] [Abstract][Full Text] [Related]
7. Sulforaphane Suppresses Hepatitis C Virus Replication by Up-Regulating Heme Oxygenase-1 Expression through PI3K/Nrf2 Pathway. Yu JS; Chen WC; Tseng CK; Lin CK; Hsu YC; Chen YH; Lee JC PLoS One; 2016; 11(3):e0152236. PubMed ID: 27023634 [TBL] [Abstract][Full Text] [Related]
8. Zinc mesoporphyrin induces rapid proteasomal degradation of hepatitis C nonstructural 5A protein in human hepatoma cells. Hou W; Tian Q; Zheng J; Bonkovsky HL Gastroenterology; 2010 May; 138(5):1909-19. PubMed ID: 19909748 [TBL] [Abstract][Full Text] [Related]
9. Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase. Furuta A; Tsubuki M; Endoh M; Miyamoto T; Tanaka J; Salam KA; Akimitsu N; Tani H; Yamashita A; Moriishi K; Nakakoshi M; Sekiguchi Y; Tsuneda S; Noda N Int J Mol Sci; 2015 Aug; 16(8):18439-53. PubMed ID: 26262613 [TBL] [Abstract][Full Text] [Related]
10. Biliverdin inhibits hepatitis C virus nonstructural 3/4A protease activity: mechanism for the antiviral effects of heme oxygenase? Zhu Z; Wilson AT; Luxon BA; Brown KE; Mathahs MM; Bandyopadhyay S; McCaffrey AP; Schmidt WN Hepatology; 2010 Dec; 52(6):1897-905. PubMed ID: 21105106 [TBL] [Abstract][Full Text] [Related]
11. Heme oxygenase-1 suppresses hepatitis C virus replication and increases resistance of hepatocytes to oxidant injury. Zhu Z; Wilson AT; Mathahs MM; Wen F; Brown KE; Luxon BA; Schmidt WN Hepatology; 2008 Nov; 48(5):1430-9. PubMed ID: 18972446 [TBL] [Abstract][Full Text] [Related]
12. A reporter-based assay for identifying hepatitis C virus inhibitors based on subgenomic replicon cells. Lee JC; Chang CF; Chi YH; Hwang DR; Hsu JT J Virol Methods; 2004 Mar; 116(1):27-33. PubMed ID: 14715304 [TBL] [Abstract][Full Text] [Related]
13. Daclatasvir-like inhibitors of NS5A block early biogenesis of hepatitis C virus-induced membranous replication factories, independent of RNA replication. Berger C; Romero-Brey I; Radujkovic D; Terreux R; Zayas M; Paul D; Harak C; Hoppe S; Gao M; Penin F; Lohmann V; Bartenschlager R Gastroenterology; 2014 Nov; 147(5):1094-105.e25. PubMed ID: 25046163 [TBL] [Abstract][Full Text] [Related]
15. Combinations of lambda interferon with direct-acting antiviral agents are highly efficient in suppressing hepatitis C virus replication. Friborg J; Levine S; Chen C; Sheaffer AK; Chaniewski S; Voss S; Lemm JA; McPhee F Antimicrob Agents Chemother; 2013 Mar; 57(3):1312-22. PubMed ID: 23274666 [TBL] [Abstract][Full Text] [Related]
16. Combination of a hepatitis C virus NS3-NS4A protease inhibitor and alpha interferon synergistically inhibits viral RNA replication and facilitates viral RNA clearance in replicon cells. Lin K; Kwong AD; Lin C Antimicrob Agents Chemother; 2004 Dec; 48(12):4784-92. PubMed ID: 15561857 [TBL] [Abstract][Full Text] [Related]
17. The heme oxygenase 1 product biliverdin interferes with hepatitis C virus replication by increasing antiviral interferon response. Lehmann E; El-Tantawy WH; Ocker M; Bartenschlager R; Lohmann V; Hashemolhosseini S; Tiegs G; Sass G Hepatology; 2010 Feb; 51(2):398-404. PubMed ID: 20044809 [TBL] [Abstract][Full Text] [Related]
18. Lipid droplet-binding protein TIP47 regulates hepatitis C Virus RNA replication through interaction with the viral NS5A protein. Vogt DA; Camus G; Herker E; Webster BR; Tsou CL; Greene WC; Yen TS; Ott M PLoS Pathog; 2013; 9(4):e1003302. PubMed ID: 23593007 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A. Vazquez C; Tan CY; Horner SM J Virol; 2019 Dec; 93(23):. PubMed ID: 31534039 [TBL] [Abstract][Full Text] [Related]
20. Deguelin inhibits HCV replication through suppressing cellular autophagy via down regulation of Beclin1 expression in human hepatoma cells. Liao W; Liu X; Yang Q; Liu H; Liang B; Jiang J; Huang J; Ning C; Zang N; Zhou B; Liao Y; Chen J; Tian L; Ho W; Abdullah AS; Kong L; Liang H; Chen H; Ye L Antiviral Res; 2020 Feb; 174():104704. PubMed ID: 31917237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]